Warning letters from the FTC and FDA come ahead of a public hearing on the increasingly popular additive.
Federal regulators cautioned three companies to stop making their “unsubstantiated advertising claims” on all the alleged benefits of CBD products, ranging from oils to soft gels to gummies.
According to the letters, the sites made all sorts of claims about serious conditions including Alzheimer’s and cancer. One letter was sent to Relievus, a pain management practice with patients in New Jersey and Pennsylvania. In one statement on the company’s website, which has since been removed, Relievus said “CBD successfully stopped cancer cells in multiple different cervical cancer varieties.
Requests for comment to the other two companies — Nutra Pure and PotNetwork Holdings — were not immediately returned. CBD is a non-intoxicating cannabis derivative. It’s become a booming multi-million dollar business that’s getting mixed into everything from jelly beans to coffee and pet products. Until that time, Gottlieb said it was “unlawful” to sell food with CBD into interstate commerce, or to market it as a dietary supplement.”
Mary Engle, associate director of the FTC’s Advertising Practices Division, said the commission was “always concerned about advertising claims affecting consumers’ health or safety, and is particularly concerned about products purporting to treat serious diseases such as Alzheimer’s and cancer. Regardless of the type of product, marketers must have solid science to back up their claims that a product can improve people’s health. Under FTC law, CBD products are no different.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA sets first public hearing on legalizing CBD to add to food and drinksWhile the federal government legalized CBD that's derived from hemp, a close cousin of marijuana, the FDA's rules still prohibit companies and restaurants from adding it to food or drinks.
Consulte Mais informação »
FDA looks into regulating CBD in food, beverages and moreThe US Food and Drug Administration announced Tuesday that it will hold a public hearing next month to discuss developing a regulatory framework for the use of CBD in consumer products, including foods and beverages.
Consulte Mais informação »
FDA, FTC send warning letters to three CBD marketers for false medical claimsThe FDA and the FTC sent warning letters to 3 companies that market cannabidiol products, saying the companies are making false claims about treating diseases such as cancer and Alzheimer's.
Consulte Mais informação »
Outgoing FDA chief Gottlieb raises 'concern' over Walgreens, CVS selling CBD productsOutgoing Food and Drug Administration Commissioner Scott Gottlieb told lawmakers Wednesday that he's uneasy about Walgreens' and CVS' recent decisions to start selling CBD products in their drugstores.
Consulte Mais informação »
FDA warns that e-cigarette use may cause seizuresThe agency has received 35 reports of seizures among e-cigarettes users, mainly in teens and young adults, since 2010.
Consulte Mais informação »
FDA to investigate reports of seizures possibly linked to e-cigarette useThe agency has received 35 reports of seizures among e-cigarettes users, mainly in teens and young adults, since 2010.
Consulte Mais informação »
U.S. FDA warns of potential seizure risk in some users of e-cigarettesThe U.S. Food and Drug Administration on Wednesday warned of potential safety ri...
Consulte Mais informação »
Vaping may cause seizures, especially among teens, FDA says“We have reports indicating that some people who use e-cigarettes, especially youth and young adults, are experiencing seizures following their use,” FDA commissioner says in a statement. - TODAYshow
Consulte Mais informação »
FDA sends letters to 20 companies in attempt to rein in stem cell industryThe enforcment action comes after years of scientists’ demands for agency to do more.
Consulte Mais informação »
Blood pressure patients can take tainted pills during valsartan shortage, FDA saysDue to a shortage of certain commonly used blood pressure drugs, the FDA took the unusual step of reminding patients that they have access to available -- if tainted -- medicines while a fresh supply of uncontaminated pills is manufactured.
Consulte Mais informação »